Prosecution Insights
Last updated: April 19, 2026

Institute Of Hematology And Blood Diseases Hospital Chinese Academy Of Medical Sciences

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17681855 Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof PETRASH, HILARY ANN 1644 Final Rejection Feb 28, 2022

Managing Institute Of Hematology And Blood Diseases Hospital Chinese Academy Of Medical Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month